Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.65 |
| ▸ | CTSK | P43235 | 1/20 | 0.65 |
| ▸ | PAM | P19021 | 1/20 | 0.65 |
| ▸ | GNPAT | O15228 | 1/20 | 0.63 |
| ▸ | MME | P08473 | 3/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | CTRB1 | P17538 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.59 |
| ▸ | TACR1 | P25103 | 1/20 | 0.58 |
| ▸ | ACE | P12821 | 2/20 | 0.57 |
| ▸ | CPA1 | P15085 | 2/20 | 0.57 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Afalanine SCHEMBL8587729 | 1.00 | CTSS (0.65) | CTSSCTSKPAMGNPATMME | |
| Afalanine SCHEMBL158613 | 1.00 | CTSS (0.65) | CTSSCTSKPAMGNPATMME | |
| Afalanine SCHEMBL158612 | 1.00 | CTSS (0.65) | CTSSCTSKPAMGNPATMME | |
| Afalanine SCHEMBL11167745 | 0.98 | CTSS (0.63) | CTSSCTSKPAMGNPATMME | |
| Afalanine SCHEMBL28376591 | 0.98 | CTSS (0.63) | CTSSCTSKPAMGNPATMME | |
| Afalanine SCHEMBL27807237 | 0.98 | CTSS (0.63) | CTSSCTSKPAMGNPATMME | |
| Afalanine SCHEMBL8054139 | 0.98 | CTSS (0.63) | CTSSCTSKPAMGNPATMME | |
| Afalanine SCHEMBL8054567 | 0.98 | CTSS (0.63) | CTSSCTSKPAMGNPATMME | |
| Afalanine SCHEMBL5493802 | 0.98 | CTSS (0.68) | CTSSCTSKPAMGNPATMME | |
| Afalanine SCHEMBL27738957 | 0.98 | CTSS (0.63) | CTSSCTSKPAMGNPATMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 464 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132101-A1 | METHOD FOR RESOLVING PHENYLALANINE DERIVATIVE, AND INTERMEDIATE | NEUBORON BIO SCITECH CO LTD (CN) | 2026-05-14 | — | — | US | claimed |
| EP-3375771-B1 | METHOD FOR PRODUCING LACOSAMIDE AND INTERMEDIATE THEREOF | UBE CORP (JP) | 2025-11-26 | — | — | EP | claimed |
| CN-119330846-A | Resolution method and intermediate of phenylalanine derivatives | 中硼（厦门）生物医药有限公司 | 2025-01-21 | — | — | CN | claimed |
| EP-3406261-B1 | SYNTHETIC ANTIGENIC PEPTIDES AND LIPOPEPTIDES DERIVED FROM MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS | PASTEUR INSTITUT (FR) | 2024-08-21 | — | — | EP | claimed |
| CN-117510398-A | Preparation method of (3R, 4R)/(3S, 4S) -N-BOC-4-amino-3-hydroxy piperidine with high optical purity | 上海诺丁太生物科技有限公司 | 2024-02-06 | — | — | CN | claimed |
| US-20240002438-A1 | MELANOCORTIN LIGANDS AND METHODS OF USE THEREOF | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES | 2024-01-04 | — | — | US | claimed |
| CN-116970008-A | Nickel complex of N-acetyl-D-phenylalanine, preparation method and application thereof | 河北师范大学 | 2023-10-31 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| EP-4171621-A1 | C825 EXPRESSING IMMUNE CELLS AND DIAGNOSTIC USES THEREOF | Memorial Sloan Kettering Cancer Center (US) | 2023-05-03 | — | — | EP | claimed |
| EP-4157293-A1 | ANTI-GD2 SADA CONJUGATES AND USES THEREOF | Memorial Sloan Kettering Cancer Center (US) | 2023-04-05 | — | — | EP | claimed |
| US-5916774-A | PRODUCES D-AMINO ACIDS FROM CORRESPONDING N-ACETYL-D-AMINO ACIDS; ACTIVITY PROMOTED BY COBALT AND CALCIUM IONS BUT INHIBITED BY COPPER, MERCURY AND ZINC IONS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-06-29 | — | — | US | claimed |
| EP-0896057-A2 | D-aminoacylase | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 1999-02-10 | — | — | EP | claimed |
| EP-0723586-A1 | ENZYME AND ITS USE IN PREPARING (S)-PIPECOLIC ACID | Chiroscience Limited (GB) | 1996-07-31 | — | — | EP | claimed |
| WO-1995010604-A1 | ENZYME AND ITS USE IN PREPARING (S)-PIPECOLIC ACID | CHIROSCIENCE LIMITED (GB) | 1995-04-20 | — | — | WO | claimed |
| EP-0174981-A4 | METHOD OF TREATING DEPRESSION IN VERTEBRATES. | ERK VERNON | 1987-11-09 | — | — | EP | claimed |
| EP-0174981-A1 | METHOD OF TREATING DEPRESSION IN VERTEBRATES. | ERK VERNON | 1986-03-26 | — | — | EP | claimed |
| WO-1985003874-A1 | METHOD OF TREATING DEPRESSION IN VERTEBRATES | ERK VERNON | 1985-09-12 | — | — | WO | claimed |
| EP-0028251-B1 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER | ETHYL CORPORATION (US) | 1983-03-16 | — | — | EP | claimed |
| US-3983162-A | Optical resolution of alkyl esters of DL-phenylalanine | G. D. SEARLE & CO. (US) | 1976-09-28 | — | — | US | claimed |
| US-3941831-A | Resolution of alkyl esters of DL-phenylalanine | G. D. SEARLE & CO. (US) | 1976-03-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132101-A1 | METHOD FOR RESOLVING PHENYLALANINE DERIVATIVE, AND INTERMEDIATE | ADH1A, ADH5, NAT1 | CTSS 1646/4885CTSK 2959/4885PAM 2405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.